Interrelations between sleep and the somatotropic axis.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing physiological and mechanistic literature without systematic search or meta-analysis.
What was done
This narrative review synthesized human and mammalian evidence evaluating the bidirectional relationship between the somatotropic axis (growth hormone [GH], growth hormone-releasing hormone [GHRH], and somatostatin) and sleep-wake regulation, including circadian shifts, aging, and pharmacological manipulation of slow-wave sleep.
What was found
In young adult men, approximately 70% of 24-hour GH output occurs during early sleep in temporal association with the first episode of slow-wave (SW) sleep; in women, the sleep-related contribution is lower and more variable. Sleep-wake homeostasis, rather than circadian phase, is the primary determinant of GH release, showing a linear relationship between SW sleep (or delta activity) and GH secretion. Pharmacological stimulation of SW sleep elevates GH release. During aging, SW sleep and GH output decline in parallel. Central GHRH appears to promote non-REM/SW sleep, while GH itself may influence REM sleep.
Why it matters
The review establishes that sleep architecture directly dictates daily growth hormone pulses, suggesting that age-related somatotropic decline is tied to sleep fragmentation and that sleep-modulating compounds could act as physiological GH secretagogues.
Limits
The paper is a qualitative narrative review with no systematic search criteria, quality scoring, or pooled effect estimates. Hypothesized dual-hypothalamic control mechanisms and specific central feedback pathways of GH on sleep remain largely inferential rather than directly demonstrated in humans.